N, S., IR, P., & KM, S. (2017). New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab. Dove Medical Press.
Chicago Style (17th ed.) CitationN, Seetharamu, Preeshagul IR, and Sullivan KM. New PD-L1 Inhibitors in Non-small Cell Lung Cancer – Impact of Atezolizumab. Dove Medical Press, 2017.
MLA (8th ed.) CitationN, Seetharamu, et al. New PD-L1 Inhibitors in Non-small Cell Lung Cancer – Impact of Atezolizumab. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.